A detailed history of N.E.W. Advisory Services LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, N.E.W. Advisory Services LLC holds 722 shares of LLY stock, worth $554,322. This represents 0.06% of its overall portfolio holdings.

Number of Shares
722
Previous 722 -0.0%
Holding current value
$554,322
Previous $653,000 2.14%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $28,994 - $36,361
40 Added 5.87%
722 $653,000
Q1 2024

Apr 24, 2024

SELL
$592.2 - $792.28 $2,961 - $3,961
-5 Reduced 0.73%
682 $530,000
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $5,777 - $6,810
11 Added 1.63%
687 $400,000
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $43,470 - $59,929
100 Added 17.36%
676 $363,000
Q2 2023

Aug 04, 2023

BUY
$350.74 - $468.98 $202,026 - $270,132
576 New
576 $270,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track N.E.W. Advisory Services LLC Portfolio

Follow N.E.W. Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N.E.W. Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on N.E.W. Advisory Services LLC with notifications on news.